Professional Employer Orgs (PEOs) can support your business and help take the headaches out of your company’s HR experience. Learn more about this program from AZBio and BIO Business Solutions®.Continue reading
Author Archive: AZBio
TGen Celebrates 20 Years of Impact
20 years ago, TGen, the Translational Genomics Research Institute was a vision our community embraced. Today, TGen is an Arizona-based, nonprofit medical research institute dedicated to conducting groundbreaking research with life-changing results. TGen works to unravel the genetic components of common and complex diseases, including cancer, neurological disorders, infectious disease, and rare childhood disorders. By identifying treatment options in this manner, TGen believes medicine becomes more rational, more precise and, well, more personal.Continue reading
FDA Clearance Granted for New Dual Lumen Catheter That Enables Precise Visualization and Treatment Access to the Left Heart
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Franklin Mountain Medical announced today that the company has received FDA clearance of its patented UltraNav Transseptal Catheter System for controlled access and delivery of cardiovascular catheters and guidewires to the heart chambers via transseptal puncture.Continue reading
Menopause and cognition: Testing an alternative to estrogen therapy
Researchers at the Center for Innovation in Brain Science received a $7.6 million grant to investigate PhytoSERM, a dietary supplement that may be able to treat menopausal symptoms and lower the risk of Alzheimer’s disease.Continue reading
Caris Life Sciences Announces Continued Growth and Investment with Opening of New Liquid Biopsy Laboratory Facility
New $45M liquid biopsy lab and diagnostic testing facility creates hundreds of new bioscience job opportunities in PhoenixContinue reading
BD Forms Sustainable Medical Technology Institute to Reduce the Environmental Impact of its Product Portfolio
Institute will drive sustainable innovation in three areas of environmental stewardship, furthering progress toward the company’s 2030+ environmental, social and governance (ESG) commitmentsContinue reading
Flinn Foundation: Arizona’s bioscience sector hits record highs 20 years into strategic plan
The April 20 report, the latest performance analysis commissioned by the Phoenix-based Flinn Foundation and presented by TEConomy Partners, shows record highs in bioscience jobs, wages, venture capital, National Institutes of Health research funding, and university research and development.Continue reading
Aqualung Therapeutics Extends Global Reach With LeaderMed License Agreement
TUCSON, AZ / ACCESSWIRE / April 20, 2022 / Aqualung Therapeutics, an early stage immunotherapeutics biotech company developing an anti-inflammatory therapeutic platform for serious unchecked inflammatory disorders, announced the signing of a license agreement with the LeaderMed Health Group Limited (“LeaderMed”). The License Agreement provides LeaderMed with Asia-Pacific regional rights to further develop, manufacture, and commercialize the eNAMPT-neutralizing mAb, ALT-100 platform technology. The terms of the agreement have not been publicly disclosed but involve customary upfront fees, achievement milestones, and royalties that coincide with commercial sales.Continue reading
Flinn Foundation awards $1 million in grants to promote groundbreaking translational research
The first treatment for West Nile virus. A robotic device for children with cerebral palsy. A universal antivenom for snake bites. These goals emerge from three of the 10 translational research projects receiving funding from the Flinn Foundation in 2022 as part of a program to advance new products and services to improve patient care.Continue reading
AlphaLogix announces market release of AlphaFlo® canine allograft
PHOENIX, March 31, 2022 /PRNewswire/ — Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®. Equus Innovations is also the manufacturer of the highly successful RenoVō® equine allograft, distributed by Equine Amnio Solutions, LLC (EAS).